Global and China Liver Cirrhosis Therapeutics Drugs Market Insights, Forecast to 2027
SKU ID : QYR-18771242 | Publishing Date : 21-Jul-2021 | No. of pages : 152
Detailed TOC of Global and China Liver Cirrhosis Therapeutics Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Liver Cirrhosis Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type
1.2.2 Oral Liver Cirrhosis Therapeutics Drugs
1.2.3 Injection Liver Cirrhosis Therapeutics Drugs
1.3 Market by Application
1.3.1 Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liver Cirrhosis Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Liver Cirrhosis Therapeutics Drugs Revenue 2016-2027
2.1.2 Global Liver Cirrhosis Therapeutics Drugs Sales 2016-2027
2.2 Global Liver Cirrhosis Therapeutics Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Liver Cirrhosis Therapeutics Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Liver Cirrhosis Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Liver Cirrhosis Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Liver Cirrhosis Therapeutics Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Region (2022-2027)
3 Global Liver Cirrhosis Therapeutics Drugs Competitor Landscape by Players
3.1 Global Top Liver Cirrhosis Therapeutics Drugs Manufacturers by Sales
3.1.1 Global Liver Cirrhosis Therapeutics Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Liver Cirrhosis Therapeutics Drugs Manufacturers by Revenue
3.2.1 Key Liver Cirrhosis Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Liver Cirrhosis Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Liver Cirrhosis Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Liver Cirrhosis Therapeutics Drugs Revenue in 2020
3.2.6 Global Liver Cirrhosis Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Liver Cirrhosis Therapeutics Drugs Price by Manufacturers
3.4 Global Liver Cirrhosis Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Liver Cirrhosis Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liver Cirrhosis Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Liver Cirrhosis Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Liver Cirrhosis Therapeutics Drugs Market Size by Type (2016-2021)
4.1.1 Global Liver Cirrhosis Therapeutics Drugs Sales by Type (2016-2021)
4.1.2 Global Liver Cirrhosis Therapeutics Drugs Revenue by Type (2016-2021)
4.1.3 Liver Cirrhosis Therapeutics Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Liver Cirrhosis Therapeutics Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Liver Cirrhosis Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2016-2021)
5.1.1 Global Liver Cirrhosis Therapeutics Drugs Sales by Application (2016-2021)
5.1.2 Global Liver Cirrhosis Therapeutics Drugs Revenue by Application (2016-2021)
5.1.3 Liver Cirrhosis Therapeutics Drugs Price by Application (2016-2021)
5.2 Liver Cirrhosis Therapeutics Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Liver Cirrhosis Therapeutics Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Liver Cirrhosis Therapeutics Drugs Market Size YoY Growth 2016-2027
6.1.1 China Liver Cirrhosis Therapeutics Drugs Sales YoY Growth 2016-2027
6.1.2 China Liver Cirrhosis Therapeutics Drugs Revenue YoY Growth 2016-2027
6.1.3 China Liver Cirrhosis Therapeutics Drugs Market Share in Global Market 2016-2027
6.2 China Liver Cirrhosis Therapeutics Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Liver Cirrhosis Therapeutics Drugs Players by Sales (2016-2021)
6.2.2 China Top Liver Cirrhosis Therapeutics Drugs Players by Revenue (2016-2021)
6.3 China Liver Cirrhosis Therapeutics Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Liver Cirrhosis Therapeutics Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Liver Cirrhosis Therapeutics Drugs Price by Type (2016-2021)
6.4 China Liver Cirrhosis Therapeutics Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Liver Cirrhosis Therapeutics Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Liver Cirrhosis Therapeutics Drugs Price Forecast by Type (2022-2027)
6.5 China Liver Cirrhosis Therapeutics Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Liver Cirrhosis Therapeutics Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Liver Cirrhosis Therapeutics Drugs Price by Application (2016-2021)
6.6 China Liver Cirrhosis Therapeutics Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Liver Cirrhosis Therapeutics Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Liver Cirrhosis Therapeutics Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Liver Cirrhosis Therapeutics Drugs Market Size YoY Growth 2016-2027
7.2 North America Liver Cirrhosis Therapeutics Drugs Market Facts & Figures by Country
7.2.1 North America Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021)
7.2.2 North America Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Liver Cirrhosis Therapeutics Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Liver Cirrhosis Therapeutics Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Liver Cirrhosis Therapeutics Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Liver Cirrhosis Therapeutics Drugs Market Size YoY Growth 2016-2027
9.2 Europe Liver Cirrhosis Therapeutics Drugs Market Facts & Figures by Country
9.2.1 Europe Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021)
9.2.2 Europe Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Liver Cirrhosis Therapeutics Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Liver Cirrhosis Therapeutics Drugs Market Facts & Figures by Country
10.2.1 Latin America Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021)
10.2.2 Latin America Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Description and Business Overview
12.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Liver Cirrhosis Therapeutics Drugs Products Offered
12.4.5 Merck Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Liver Cirrhosis Therapeutics Drugs Products Offered
12.5.5 Roche Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Conatus Pharmaceuticals
12.7.1 Conatus Pharmaceuticals Corporation Information
12.7.2 Conatus Pharmaceuticals Description and Business Overview
12.7.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Products Offered
12.7.5 Conatus Pharmaceuticals Recent Development
12.8 Gwo Xi Stem Cell Applied Technology
12.8.1 Gwo Xi Stem Cell Applied Technology Corporation Information
12.8.2 Gwo Xi Stem Cell Applied Technology Description and Business Overview
12.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Products Offered
12.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
12.9 Instituto Grifols
12.9.1 Instituto Grifols Corporation Information
12.9.2 Instituto Grifols Description and Business Overview
12.9.3 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Products Offered
12.9.5 Instituto Grifols Recent Development
12.10 Intercept Pharmaceuticals
12.10.1 Intercept Pharmaceuticals Corporation Information
12.10.2 Intercept Pharmaceuticals Description and Business Overview
12.10.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Products Offered
12.10.5 Intercept Pharmaceuticals Recent Development
12.11 Gilead Sciences
12.11.1 Gilead Sciences Corporation Information
12.11.2 Gilead Sciences Description and Business Overview
12.11.3 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Products Offered
12.11.5 Gilead Sciences Recent Development
12.12 Norgine
12.12.1 Norgine Corporation Information
12.12.2 Norgine Description and Business Overview
12.12.3 Norgine Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Norgine Products Offered
12.12.5 Norgine Recent Development
12.13 Pharmicell
12.13.1 Pharmicell Corporation Information
12.13.2 Pharmicell Description and Business Overview
12.13.3 Pharmicell Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Pharmicell Products Offered
12.13.5 Pharmicell Recent Development
12.14 Salix Pharmaceuticals
12.14.1 Salix Pharmaceuticals Corporation Information
12.14.2 Salix Pharmaceuticals Description and Business Overview
12.14.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Salix Pharmaceuticals Products Offered
12.14.5 Salix Pharmaceuticals Recent Development
12.15 Stempeutics Research
12.15.1 Stempeutics Research Corporation Information
12.15.2 Stempeutics Research Description and Business Overview
12.15.3 Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Stempeutics Research Products Offered
12.15.5 Stempeutics Research Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Liver Cirrhosis Therapeutics Drugs Industry Trends
13.2 Liver Cirrhosis Therapeutics Drugs Market Drivers
13.3 Liver Cirrhosis Therapeutics Drugs Market Challenges
13.4 Liver Cirrhosis Therapeutics Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liver Cirrhosis Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China Liver Cirrhosis Therapeutics Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral Liver Cirrhosis Therapeutics Drugs
Table 3. Major Manufacturers of Injection Liver Cirrhosis Therapeutics Drugs
Table 4. Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 5. Global Liver Cirrhosis Therapeutics Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Liver Cirrhosis Therapeutics Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 7. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Liver Cirrhosis Therapeutics Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Liver Cirrhosis Therapeutics Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 14. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Liver Cirrhosis Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Liver Cirrhosis Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Liver Cirrhosis Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Liver Cirrhosis Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cirrhosis Therapeutics Drugs as of 2020)
Table 20. Key Manufacturers Liver Cirrhosis Therapeutics Drugs Price (2016-2021) (USD/Pcs)
Table 21. Liver Cirrhosis Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Liver Cirrhosis Therapeutics Drugs Product Type
Table 23. Date of International Manufacturers Enter into Liver Cirrhosis Therapeutics Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Liver Cirrhosis Therapeutics Drugs Sales by Type (2016-2021) (K Pcs)
Table 26. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Type (2016-2021)
Table 27. Global Liver Cirrhosis Therapeutics Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Liver Cirrhosis Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 29. Liver Cirrhosis Therapeutics Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 30. Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 31. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Liver Cirrhosis Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 35. Global Liver Cirrhosis Therapeutics Drugs Sales by Application (2016-2021) (K Pcs)
Table 36. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Application (2016-2021)
Table 37. Global Liver Cirrhosis Therapeutics Drugs Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Liver Cirrhosis Therapeutics Drugs Revenue Share by Application (2016-2021)
Table 39. Liver Cirrhosis Therapeutics Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 40. Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 41. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Liver Cirrhosis Therapeutics Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 45. China Liver Cirrhosis Therapeutics Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 46. China Liver Cirrhosis Therapeutics Drugs Sales Share by Company (2016-2021)
Table 47. China Liver Cirrhosis Therapeutics Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. China Liver Cirrhosis Therapeutics Drugs Revenue Share by Company (2016-2021)
Table 49. China Liver Cirrhosis Therapeutics Drugs Sales (K Pcs) by Type (2016-2021)
Table 50. China Liver Cirrhosis Therapeutics Drugs Sales Share by Type (2016-2021)
Table 51. China Liver Cirrhosis Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Liver Cirrhosis Therapeutics Drugs Price (USD/Pcs) by Type (2016-2021)
Table 53. China Liver Cirrhosis Therapeutics Drugs Sales (K Pcs) by Type (2022-2027)
Table 54. China Liver Cirrhosis Therapeutics Drugs Sales Share by Type (2022-2027)
Table 55. China Liver Cirrhosis Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Liver Cirrhosis Therapeutics Drugs Revenue Share by Type (2022-2027)
Table 57. China Liver Cirrhosis Therapeutics Drugs Price (USD/Pcs) by Type (2022-2027)
Table 58. China Liver Cirrhosis Therapeutics Drugs Sales (K Pcs) by Application (2016-2021)
Table 59. China Liver Cirrhosis Therapeutics Drugs Sales Share by Application (2016-2021)
Table 60. China Liver Cirrhosis Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Liver Cirrhosis Therapeutics Drugs Price (USD/Pcs) by Application (2016-2021)
Table 62. China Liver Cirrhosis Therapeutics Drugs Sales (K Pcs) by Application (2022-2027)
Table 63. China Liver Cirrhosis Therapeutics Drugs Sales Share by Application (2022-2027)
Table 64. China Liver Cirrhosis Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Liver Cirrhosis Therapeutics Drugs Revenue Share by Application (2022-2027)
Table 66. China Liver Cirrhosis Therapeutics Drugs Price (USD/Pcs) by Application (2022-2027)
Table 67. North America Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021) & (K Pcs)
Table 68. North America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales by Region (2016-2021) & (K Pcs)
Table 72. Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Liver Cirrhosis Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021) & (K Pcs)
Table 76. Europe Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021) & (K Pcs)
Table 80. Latin America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales by Country (2016-2021) & (K Pcs)
Table 84. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 87. Gilead Sciences Corporation Information
Table 88. Gilead Sciences Description and Business Overview
Table 89. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 90. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Product
Table 91. Gilead Sciences Recent Development
Table 92. GlaxoSmithKline Corporation Information
Table 93. GlaxoSmithKline Description and Business Overview
Table 94. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 95. GlaxoSmithKline Product
Table 96. GlaxoSmithKline Recent Development
Table 97. Johnson & Johnson Corporation Information
Table 98. Johnson & Johnson Description and Business Overview
Table 99. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Recent Development
Table 102. Merck Corporation Information
Table 103. Merck Description and Business Overview
Table 104. Merck Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 105. Merck Product
Table 106. Merck Recent Development
Table 107. Roche Corporation Information
Table 108. Roche Description and Business Overview
Table 109. Roche Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 110. Roche Product
Table 111. Roche Recent Development
Table 112. Bristol-Myers Squibb Corporation Information
Table 113. Bristol-Myers Squibb Description and Business Overview
Table 114. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Bristol-Myers Squibb Product
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Conatus Pharmaceuticals Corporation Information
Table 118. Conatus Pharmaceuticals Description and Business Overview
Table 119. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. Conatus Pharmaceuticals Product
Table 121. Conatus Pharmaceuticals Recent Development
Table 122. Gwo Xi Stem Cell Applied Technology Corporation Information
Table 123. Gwo Xi Stem Cell Applied Technology Description and Business Overview
Table 124. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. Gwo Xi Stem Cell Applied Technology Product
Table 126. Gwo Xi Stem Cell Applied Technology Recent Development
Table 127. Instituto Grifols Corporation Information
Table 128. Instituto Grifols Description and Business Overview
Table 129. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. Instituto Grifols Product
Table 131. Instituto Grifols Recent Development
Table 132. Intercept Pharmaceuticals Corporation Information
Table 133. Intercept Pharmaceuticals Description and Business Overview
Table 134. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. Intercept Pharmaceuticals Product
Table 136. Intercept Pharmaceuticals Recent Development
Table 137. NGM Biopharmaceuticals Corporation Information
Table 138. NGM Biopharmaceuticals Description and Business Overview
Table 139. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 140. NGM Biopharmaceuticals Product
Table 141. NGM Biopharmaceuticals Recent Development
Table 142. Norgine Corporation Information
Table 143. Norgine Description and Business Overview
Table 144. Norgine Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 145. Norgine Product
Table 146. Norgine Recent Development
Table 147. Pharmicell Corporation Information
Table 148. Pharmicell Description and Business Overview
Table 149. Pharmicell Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 150. Pharmicell Product
Table 151. Pharmicell Recent Development
Table 152. Salix Pharmaceuticals Corporation Information
Table 153. Salix Pharmaceuticals Description and Business Overview
Table 154. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 155. Salix Pharmaceuticals Product
Table 156. Salix Pharmaceuticals Recent Development
Table 157. Stempeutics Research Corporation Information
Table 158. Stempeutics Research Description and Business Overview
Table 159. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 160. Stempeutics Research Product
Table 161. Stempeutics Research Recent Development
Table 162. Liver Cirrhosis Therapeutics Drugs Market Trends
Table 163. Liver Cirrhosis Therapeutics Drugs Market Drivers
Table 164. Liver Cirrhosis Therapeutics Drugs Market Challenges
Table 165. Liver Cirrhosis Therapeutics Drugs Market Restraints
Table 166. Liver Cirrhosis Therapeutics Drugs Customers List
Table 167. Liver Cirrhosis Therapeutics Drugs Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Liver Cirrhosis Therapeutics Drugs Product Picture
Figure 2. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Oral Liver Cirrhosis Therapeutics Drugs Product Picture
Figure 4. Injection Liver Cirrhosis Therapeutics Drugs Product Picture
Figure 5. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Liver Cirrhosis Therapeutics Drugs Report Years Considered
Figure 10. Global Liver Cirrhosis Therapeutics Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Liver Cirrhosis Therapeutics Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Liver Cirrhosis Therapeutics Drugs Sales 2016-2027 (K Pcs)
Figure 13. Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Region (2016-2021)
Figure 15. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Region in 2020
Figure 16. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Figure 17. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 18. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Liver Cirrhosis Therapeutics Drugs Revenue in 2020
Figure 20. Liver Cirrhosis Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Type (2016-2021)
Figure 22. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Type in 2020
Figure 23. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Type in 2020
Figure 25. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Application in 2020
Figure 27. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Application (2016-2021)
Figure 28. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Application in 2020
Figure 29. China Liver Cirrhosis Therapeutics Drugs Sales Growth Rate 2016-2027 (K Pcs)
Figure 30. China Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Liver Cirrhosis Therapeutics Drugs Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Liver Cirrhosis Therapeutics Drugs Players Market Share by Revenue in Liver Cirrhosis Therapeutics Drugs in 2020
Figure 33. China Liver Cirrhosis Therapeutics Drugs Revenue Share by Type (2016-2021)
Figure 34. China Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Liver Cirrhosis Therapeutics Drugs Revenue Share by Application (2016-2021)
Figure 36. China Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Liver Cirrhosis Therapeutics Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 38. North America Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country in 2020
Figure 40. North America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 41. U.S. Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 42. U.S. Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. Canada Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Liver Cirrhosis Therapeutics Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 46. Europe Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country in 2020
Figure 48. Europe Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 49. Germany Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 50. Germany Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. France Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. U.K. Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. Italy Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Russia Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 60. Asia Pacific Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales Market Share by Region in 2020
Figure 62. Asia Pacific Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 63. China Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 64. China Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. Japan Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. South Korea Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. India Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. Australia Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. China Taiwan Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Indonesia Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Thailand Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Malaysia Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Liver Cirrhosis Therapeutics Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 82. Latin America Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country in 2020
Figure 84. Latin America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 85. Mexico Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Mexico Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Brazil Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 90. Argentina Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 92. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Country in 2020
Figure 95. Turkey Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Turkey Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 98. Saudi Arabia Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Liver Cirrhosis Therapeutics Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 100. UAE Liver Cirrhosis Therapeutics Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Liver Cirrhosis Therapeutics Drugs Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
Keyplayers in Global and China Liver Cirrhosis Therapeutics Drugs Market Insights, Forecast to 2027
Gilead SciencesGlaxoSmithKline
Johnson & Johnson
Merck
Roche
Bristol-Myers Squibb
Conatus Pharmaceuticals
Gwo Xi Stem Cell Applied Technology
Instituto Grifols
Intercept Pharmaceuticals
NGM Biopharmaceuticals
Norgine
Pharmicell
Salix Pharmaceuticals
Stempeutics Research